The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria‐mediated apoptosis and DNA damage in p53 mutant leukemic T cells
Open Access
- 31 March 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 130 (5) , 1195-1207
Abstract
DNA methyltransferase (DNMT)‐inhibiting nucleoside analogs reactivate the expression of tumor suppressor genes and apoptosis‐related genes silenced by methylation, thus favoring the induction of apoptosis in tumor cells. Moreover, induction of DNA damage seems to contribute to their antitumor effect. However, the apoptotic signaling pathway induced by these demethylating drugs is not well understood. Here, we have investigated the induction of apoptosis by two nucleoside DNMT inhibitors, decitabine and zebularine, in leukemic T cells. Both inhibitors induced caspase‐dependent apoptosis in Jurkat, CEM‐6 and MOLT‐4 leukemia T cell lines, all with mutant p53, whereas resting and activated normal T lymphocytes were highly resistant to these demethylating agents. Although decitabine and zebularine showed different ability to induce apoptosis and cell cycle arrest among the three cell lines, they similarly activated the intrinsic apoptotic pathway by inducing mitochondrial alterations such as Bak activation, loss of transmembrane potential and generation of reactive oxygen species (ROS). Accordingly, Bcl‐2‐ and Bcl‐xL‐overexpressing Jurkat cells, as well as caspase‐9‐deficient Jurkat cells, were resistant to apoptosis induced by decitabine and zebularine. Interestingly, ROS production seemed to be necessary for the induction of apoptosis. Apoptotic events, such as Bak and caspase activation, started as soon as 20 hr after treatment with either decitabine or zebularine. In addition, progression of apoptosis triggered by both DNMT inhibitors was paralleled by the induction of DNA damage. Our results suggest that the mitochondrial apoptotic pathway activated by decitabine and zebularine in p53 mutant leukemic T cells depends mainly on the induction of DNA damage.Keywords
This publication has 51 references indexed in Scilit:
- DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target siteBiochemical Pharmacology, 2009
- Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell linesBlood, 2009
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabineInternational Journal of Cancer, 2008
- p21WAF1/CIP1 induction by 5-azacytosine nucleosides requires DNA damageOncogene, 2008
- DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3BMolecular and Cellular Biology, 2008
- Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applicationsJournal of Cellular Physiology, 2007
- Gene silencing by DNA methylation in haematological malignanciesBritish Journal of Haematology, 2007
- Loss of Caspase-9 Reveals Its Essential Role for Caspase-2 Activation and Mitochondrial Membrane DepolarizationMolecular Biology of the Cell, 2007
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- 5‐Aza‐2′‐deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53‐independent apoptosis in myeloid leukemiaInternational Journal of Cancer, 2005